Literature DB >> 3004706

Effects of amiloride on thermosensitivity of Chinese hamster cells under neutral and acidic pH.

J Miyakoshi, W Oda, M Hirata, N Fukuhori, C Inagaki.   

Abstract

The modifying effects of amiloride on the thermosensitivity of Chinese hamster V-79 cells were examined under both neutral (pH 7.3) and acidic (pH 6.6) conditions. Amiloride, a diuretic drug, is known to inhibit the Na+/H+ exchange activity. Under the extracellular pH of 7.3, amiloride (0.1-0.5 mM) enhanced the thermal cell killing powers of 42 degrees C hyperthermia with increasing concentration and exposure time of the drug. The age response of cells to 42 degrees C hyperthermia in the presence or absence of amiloride (0.5 mM) showed that amiloride sensitized cells to heat, especially those at G1-S boundary through middle S phases. On the other hand, the lowering of extracellular pH to 6.6 enhanced cell killing by 42 degrees C hyperthermia. When cells were exposed to 42 degrees C hyperthermia in the presence of amiloride at pH 6.6, cell survival decreased still more. The thermosensitizing effects of the lowered pH at 6.6 and amiloride appeared to be additive. From these results, it is suggested that the thermosensitization by amiloride is probably due, in part, to the inhibition of cellular Na+/H+ exchange activity. The present study proposes the possibility that amiloride may be useful as a hyperthermic sensitizer in a clinical treatment of cancer.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3004706

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  2 in total

1.  Effect of mitomycin C, verapamil, and hyperthermia on human gastric adenocarcinoma.

Authors:  I B Shchepotin; R R Buras; R J Nauta; M Shabahang; S R Evans
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

2.  The chronic administration of drugs that inhibit the regulation of intracellular pH: in vitro and anti-tumour effects.

Authors:  M Yamagata; I F Tannock
Journal:  Br J Cancer       Date:  1996-06       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.